{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:27:10Z","timestamp":1761823630877},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ygyno.2014.02.032","type":"journal-article","created":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T01:02:20Z","timestamp":1393635740000},"page":"250-255","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival"],"prefix":"10.1016","volume":"133","author":[{"given":"David","family":"Ly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Braden D.","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark K.","family":"Dodson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pat A.","family":"Soisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Jolles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David K.","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T.","family":"Sause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2014.02.032_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0010","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/IGC.0b013e3182412ebd","article-title":"Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology","volume":"22","author":"Page","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0015","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","article-title":"Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers","volume":"94","author":"Hamilton","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ygyno.2004.08.019","article-title":"Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium","volume":"95","author":"Creasman","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(02)02913-9","article-title":"Is there a difference in outcome between stage I-II endometrial cancer of papillary serous\/clear cell and endometrioid FIGO Grade 3 cancer?","volume":"54","author":"Alektiar","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2009.06.011","article-title":"Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review","volume":"115","author":"Boruta","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2009.02.003","article-title":"Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review","volume":"113","author":"Olawaiye","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0040","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0045","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1200\/JCO.2013.48.8023","article-title":"Long-term outcomes after pelvic radiation for early-stage endometrial cancer","volume":"31","author":"Onsrud","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3802\/jgo.2013.24.2.120","article-title":"A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system","volume":"24","author":"Kim","year":"2013","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijrobp.2012.03.011","article-title":"The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer","volume":"85","author":"Barney","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2012.12.026","article-title":"Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer","volume":"129","author":"Townamchai","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0070","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0075","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0080","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0085","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/IGC.0b013e31828b15cb","article-title":"Adjuvant radiation therapy for patients with type II endometrial carcinoma: impact on tumor recurrence and survival","volume":"23","author":"Yechieli","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0090","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2009.07.030","article-title":"An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)","volume":"115","author":"Fader","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0095","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/cncr.11830","article-title":"Is endometrial carcinoma intrinsically more aggressive in elderly patients?","volume":"98","author":"Alektiar","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ygyno.2012.04.011","article-title":"The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma","volume":"126","author":"Vance","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/gyno.2000.5737","article-title":"The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma","volume":"77","author":"Cirisano","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2005.06.012","article-title":"Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy","volume":"98","author":"Kelly","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0115","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ygyno.2013.03.011","article-title":"Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas","volume":"129","author":"Ayeni","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ygyno.2012.07.112","article-title":"Five-year outcomes of adjuvant carboplatin\/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer","volume":"127","author":"Kiess","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.02.032_bb0125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2013.09.012","article-title":"The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma","volume":"131","author":"Jutzi","year":"2013","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814001772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814001772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T22:39:03Z","timestamp":1565217543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814001772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0090825814001772"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.02.032","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.02.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}